Gapping up
In reaction to earnings/guidance:
- POWW +7.5%
Other news:
- VTNR +43.2% (VTNR to sell used motor oil collection and re-refining assets to CLH for $140 mln)
- HCM +15.9% (announces the closing of the global offering and the primary listing in Hong Kong)
- LYRA +9.6% (topline results of pharmacokinetic study of LYR-210 in patients with chronic rhinosinusitis)
- WOW +9.5% (entered into two separate definitive agreements to sell its Cleveland and Columbus, Ohio, service areas and its Chicago, Evansville, Indiana, and Anne Arundel, Maryland, service areas for $1.125 billion and $661 million, respectively)
- AVIR +7.5% (reports Phase 2 study evaluating AT-527 showed reduced viral replication in hospitalized patients with COVID-19 in phase 2 interim analysis)
- CYT +5.7% (RA Capital discloses 9.4% stake)
- NTLA +4.2% (prices offering of 4,137,931 shares of its common stock at $145.00 per share)
- VAL +3.3% (awarded extension to jackup contract)
- OBSV +2.3% (presents clinical data on open-label pilot study of Yselty)
- CFLT +1.4% (Coatue Management discloses 9.99% stake)
- ATHX +1.4% (publicantion in peer-reviewed journal Scientific Reports provides further clarity of MultiStem's mechanism of action on modulating the inflammatory response in critical care indications)
- VERI +1.3% (announced that it has partnered with Authentic Brands Group to serve as the official video technology and licensing partner for Sports Illustrated)
Analyst comments:
- MAS +2.8% (upgraded to Buy from Neutral at Goldman)
- MU +1.3% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- HXL +0.8% (upgraded to Neutral from Underperform at Credit Suisse)